Global Insulin Delivery Pens Market Current and Future Projections 2022-2032

The global Insulin Delivery Pens Market is expected to enjoy a valuation of US$ 22.4 Bn by the end of the year 2022, and further expand at a CAGR rate of 8.0% to reach a valuation of ~US$ 48.6 Bn by the year 2032. Insulin pens are an effective diabetes management solution. With current technological advancements, insulin now comes in a variety of forms, such as reusable pens that can be used by simply loading insulin cartridges sold in packs. Disposable insulin pens contain a prefilled cartridge and are disposed of or thrown away after providing convenient insulin delivery. The most recent advancement in diabetes management is the use of smart insulin pens. These smart insulin pens are either Bluetooth enabled wireless devices that allow automatic data sharing or devices that require data sharing through a dedicated USB data cable. These pens also include a clinician-configured bolus calculator and the ability to deliver multiple insulin doses safely and discreetly every day.

Global Insulin Delivery Pens Market: Dynamics

Several factors contribute to the global insulin delivery pens market's expansion. One major driver is the shift away from unit-priced payment models, which are more commonly used to self-administer treatment for chronic diseases like diabetes, and toward value-based compensation models for therapies. The shift is most noticeable in regions such as the United States and Europe. This shift, in turn, increases demand for technology-driven insulin delivery systems with higher levels of accuracy and patient compliance, as well as the necessary coaching and education. Global demand for smart insulin pens has also increased as healthcare stakeholders seek useful information from clinical trials and the real world. Furthermore, because diabetes is a chronic and expensive disease, people seek ways to reduce the costs associated with regular diabetes check-ups. Smart insulin pens provide patients with all of the necessary dosage data pertaining to the disease and its effective management.

Global Insulin Delivery Pens Market: Segmental Highlights

The global market for insulin delivery pens is divided into several segments based on product type, indication, distribution channel, and region. The report analyses each market segment, including the yearly growth rate, revenue share, and pricing analysis. The following are some of the report's key segmental highlights:

Among the regional markets, North America is expected to emerge as the revenue leader, with a market value of nearly US$ 2,000 Mn in 2017 and an estimated market value of more than US$ 5,500 Mn by the end of the forecast period in 2027.

Reusable insulin pens are expected to dominate the market in terms of revenue share in the product type segmentation. Refillable insulin pens are expected to maintain a high market valuation throughout the forecast period, reaching an estimated US$ 9,183.0 Mn by 2027, with a CAGR of 10.2%.

The market is divided into Diabetes Type 1 and Diabetes Type 2, with the Diabetes Type 2 segment leading the market, with a market valuation expected to exceed US$ 12,300 Mn by the end of 2027, growing at a CAGR of 10.5% during the forecast period.

The hospital pharmacy segment is expected to maintain its dominance in the distribution channel category, with a market value of more than US$ 1,900 Mn in 2017. This segment competes with the online sales segment, which has a higher CAGR than the hospital pharmacy segment, growing at a rate of 11.7% during the forecast period.

Global Insulin Delivery Pens Market: Competitive Landscape

This research report includes a brief profile of some of the major players in the global insulin delivery pens market. These descriptive profiles provide information on the overall development of the companies along with their future strategies. Some of the companies featured in the report are Sanofi S.A., Companion Medical, Inc., Patients Pending Ltd, Diamesco Co., Ltd., DiabNext, Owen Mumford Ltd, and Emperra GmbH E-Health Technologies.

Read More@ https://www.futuremarketinsights.com/reports/insulin-delivery-pens-market

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Aesthetic Medical Devices Market 2022-2032: Advanced R&D Process Strategies

Image
A recently published study by FMI expects the global  Aesthetic Medical Devices Market  to augment at a 9.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 35000 Million is expected for the market. The increase may be attributed mostly to the increased development of technologically advanced and user-friendly devices, as well as the rising desire for cosmetic treatments among individuals. In addition to that, the popularity of minimally invasive and non-invasive aesthetic operations is expanding internationally as a result of loose facial skin, particularly around the eyes, jowls, and cheeks; and dry or roughened skin, among other important changes that occur as a person ages. Furthermore, the demand for aesthetic devices is rising due to the growing popularity of cosmetic operations among those seeking to improve their looks and stand out from the crowd. Key Takeaways from the Market Study FMI projects the global aesthetic medical d
Read more